Setting Up A New Shop Oregon s former governor is pushing a rational way to control drug
costs. Sarah Harney | December 2003
To tame the prescription drug costs in their Medicaid programs, states are trying everything from limiting prescription coverage to eyeing Canadian-based purchasing. John Kitzhaber, a former governor of Oregon and physician, and Mark Gibson, his health policy adviser for eight years, are plotting another approach: Provide states with clinical information about the relative effectiveness of drugs so they can compare prices.
It s an approach that Oregon, Washington and Idaho started partnering to use a few years ago. They researched information about the effectiveness of several classes of medications, such as cholesterol- lowering drugs, ulcer drugs and long-term painkillers, and then encouraged doctors to prescribe the least-costly effective medications. When the three states wanted to expand the research t
1.
Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR. Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016.
2.
Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.
3.
Hepatitis B basic information. US Department of Health and Human Services. Published August 21, 2020. Accessed November 18, 2020. https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-b-basics/index.htmlPubMed
4.
Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM; High Value Care Task Force of the American College of Physicians and the Centers for Disease Control and Prevention. Hepatitis B vaccination, screening, and lin